Homozygous Familial Hypercholesterolemia in Spain

Simple item page
dc.contributor.authorRosa M. Sánchez-Hernández
dc.contributor.authorFernando Civeira
dc.contributor.authorMarianne Stef
dc.contributor.authorSofía Pérez‐Calahorra
dc.contributor.authorFátima Almagro
dc.contributor.authorNúria Plana
dc.contributor.authorFrancisco J. Nóvoa
dc.contributor.authorPedro Sáenz-Aranzubía
dc.contributor.authorDaniel Mosquera
dc.contributor.authorCristina Soler
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T13:55:41Z
dc.date.available2026-03-22T13:55:41Z
dc.date.issued2016
dc.descriptionCitaciones: 71
dc.description.abstractHoFH frequency in Spain was higher than expected. Clinical criteria would underestimate the actual prevalence of individuals with genetic HoFH, highlighting the importance of genetic analysis to improve familial hypercholesterolemia diagnosis accuracy.
dc.identifier.doi10.1161/circgenetics.116.001545
dc.identifier.urihttps://doi.org/10.1161/circgenetics.116.001545
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/43537
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofCirculation Cardiovascular Genetics
dc.sourceUniversity of Andorra
dc.subjectFamilial hypercholesterolemia
dc.subjectPCSK9
dc.subjectLDL receptor
dc.subjectApolipoprotein B
dc.subjectMedicine
dc.subjectCompound heterozygosity
dc.subjectDyslipidemia
dc.subjectInternal medicine
dc.subjectDisease
dc.subjectLipoprotein
dc.titleHomozygous Familial Hypercholesterolemia in Spain
dc.typearticle

Files

Collections

Artículo Científico Publicado